Performce Medium CROMagar Staph. Aureus
Performce Medium CROMagar Staph. Aureus
Performce Medium CROMagar Staph. Aureus
25812583
0095-1137/01/$04.000 DOI: 10.1128/JCM.39.7.25812583.2001
Copyright 2001, American Society for Microbiology. All Rights Reserved.
CHROMagar Staph aureus (CSAM) (CHROMagar Microbiology, Paris, France) is a new chromogenic medium designed to enable detection of colonies of Staphylococcus aureus by their pink color. A total of 775 specimens were cultured in parallel on CHROMagar Staph aureus and conventional media. Among the 267 S. aureus strains recovered on at least one medium, 263 were isolated on CSAM medium (sensitivity, 98.5%), and
245 (sensitivity, 91.8%) were isolated on conventional media. The specificity of presumptive identification of S. aureus on the basis of pink colony color on CSAM medium was 97% (493 of 508). This specificity increased to 100%
when coagulase detection with the Staphychrom coagulase test was added and to 98.8% when S. aureus surface
components were detected by agglutination in the Pastorex Staph Plus test. Susceptibility testing of 67 S. aureus
strains, performed in parallel on pink CSAM colonies and on colonies grown on blood agar, gave similar results. Thus, rapid and accurate recognition and identification of S. aureus isolates were achieved with CSAM
as the primary isolation medium, followed by the staphylocoagulase Staphychrom test. Antimicrobial susceptibility testing (disk-diffusion method or ATB STAPH System) can be performed directly on pink CSAM colonies.
staphylococcal species are also coagulase positive (e.g., Staphylococcus intermedius) even if they are rarely detected in human specimens (9, 14). The Staphychrom coagulase test is a
fluorogenic staphylocoagulase test based on human prothrombin and protease inhibitors and specifically detects S. aureus
coagulase (8; A. Treny, M. Bes, N. Fonsale, A. Carricajo, M. E.
Reverdy, and A. M. Freydiere, Abstr. 11th Eur. Congr. Clin.
Microbiol. Infect. Dis., abstr. P1512, p. 326327, 2001).
We assessed the performance of CSAM by culturing 775
clinical samples; all pink colonies were then submitted to the
Staphychrom coagulase test. Results were compared with
those obtained with conventional culture media, the Pastorex
Staph Plus agglutination kit, and the conventional coagulase
tube test.
(This work was presented in part at the 100th General Meeting of the American Society for Microbiology, Los Angeles,
Calif., 21 to 25 May 2000.)
2582
CARRICAJO ET AL.
J. CLIN. MICROBIOL.
No. of false
negatives
Sensitivity
(%)
Standard methoda
CSAMb
Any media
245
263
267c
22
4
91.8
98.5
100
a
Suggestive colony morphology and Gram staining, positive catalase test, and
positive latex agglutination.
b
Mauve colony and suggestive Gram staining.
c
Total number of S. aureus isolates recovered by at least one method.
Identification of S. aureus. All pink colonies grown on CSAM agar were Gram
stained and agglutinated with the Pastorex Staph Plus kit; coagulase production
was detected using the Staphychrom test according to the manufacturers recommendations. Colonies grown on conventional agar were suspected to be
staphylococcal on the basis of their morphology, Gram staining, and catalase
positivity. Catalase-positive colonies and gram-positive cocci were agglutinated
with the Pastorex Staph Plus kit, and coagulase production was detected with
EDTA-rabbit plasma (Difco Laboratories, Detroit, Mich.). When the result of
the latex agglutination test differed from that of the coagulase test, identification
was performed with the API ID32 STAPH gallery (bioMerieux) or the Accuprobe test (bioMerieux), which detects S. aureus-specific rRNA sequences.
Susceptibility testing. Antimicrobial susceptibility testing was performed by
picking colonies directly from CSAM and conventional media. The disk-diffusion
method on Mueller-Hinton agar (bioMerieux) was used at Antiquaille hospital
according to the recommendations of the Comite Francais de lAntibiogramme
(3). The methicillin susceptibility test was performed with a 5-g oxacillin disk,
a 108-CFU/ml inoculum, and incubation at 30C for 24 h. The automated ATB
STAPH System (bioMerieux) was used at Bellevue hospital, according to the
manufacturers recommendations. Briefly, a 0.5 McFarland emulsion of isolated colonies in sterile saline was added to 7 ml of ATB medium (MuellerHinton broth supplemented with 5% NaCl). The final inoculum was transferred
into an oxacillin (2 g/ml) well and incubated for 24 h at 35C. The antibiotics
tested were penicillin G, oxacillin, erythromycin, lincomycin, pristinamycin, tetracycline, kanamycin, tobramycin, gentamicin, rifampin, fusidic acid, fosfomycin,
pefloxacin, cotrimoxazole, vancomycin, and teicoplanin.
RESULTS
Detection of S. aureus. A total of 267 S. aureus strains (25%
methicillin-resistant strains) were isolated from CSAM and/or
conventional media (Table 1). Two hundred sixty-three isolates grew on CSAM: 242 (92%) grew after 24 h and 21 (8%)
after 48 h. Two hundred forty-three isolates grew on conventional media. Four isolates were not detected on CSAM and 22
were not detected on conventional media (13 isolates were
masked or inhibited by a gram-negative species, 7 were mixed
with several other coagulase-negative staphylococci, and 2 isolates corresponded to samples containing too few colonies).
The sensitivities of CSAM and conventional media for growing
S. aureus were 98.5 and 91.8%, respectively.
Fifteen pink colonies that grew on CSAM were subsequently
identified as species other than S. aureus. None of them produced coagulase in the Staphychrom coagulase test, while
six agglutinated in the Pastorex Staph Plus test and were identified as Staphylococcus simulans, Staphylococcus intermedius,
S. schleiferi, or Staphylococcus warneri by using the API STAPH
gallery (Table 2). The isolates which were neither coagulase
positive nor agglutination positive belonged to other coagulase-negative Staphylococcus species or were micrococci (Table 2). Five of these 15 strains were detected after 48 h of
incubation. In addition, 55 Corynebacterium spp., 3 Candida
Micrococcus spp.
Staphylococcus epidermidis
Staphylococcus simulans
Staphylococcus intermedius
Staphylococcus warneri
Staphylococcus schleiferi
Other coagulase-negative
Staphylococcus spp.
Total
a
CSAMb
CSAMb
Pastorex Staph
Plus test
CSAMb
Staphychrom
coagulase test
2
3
3c
1
1
1
4
0
0
3c
1
1
1
0
0
0
0
0
0
0
0
15
Specificities were the following: for CSAM, 97%; for CSAM Pastorex
Staph Plus test, 98.8%; for CSAM Staphychrom coagulase test, 100%.
b
Mauve colony and suggestive Gram staining, but not an S. aureus strain.
c
These three strains were isolated from different specimens from the same
patient.
2583
REFERENCES
1. Carricajo, A., S. Boiste, J. Thore, G. Aubert, Y. Gille, and A. M. Freydiere.
1999. Comparative evaluation of five chromogenic media for detection, enumeration and identification of urinary tract pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 18:796803.
2. Celard, M., F. Vandenesch, H. Darbas, J. Grando, H. Jean-Pierre, G. Kirkorian, and J. Etienne. 1997. Pacemaker infection caused by Staphylococcus
schleiferi, a member of the human preaxillary flora: four case reports. Clin.
Infect. Dis. 24:10141015.
3. Comite de lantibiogramme de la Societe Francaise de Microbiologie. 1998.
Communique. Pathol. Biol. 46:116.
4. Fleurette, J., M. Be`s, I. Brun, J. Freney, F. Forey, M. Coulet, M. E. Reverdy,
and J. Etienne. 1989. Clinical isolates of Staphylococcus lugdunensis and
S. schleiferi: bacteriological characteristics and susceptibility to antimicrobial
agents. Res. Microbiol. 140:107118.
5. Freydiere, A. M., L. Buchaille, and Y. Gille. 1997. Comparison of three
media for direct identification and discrimination of Candida spp. in clinical
specimens. Eur. J. Clin. Microbiol. Infect. Dis. 16:464467.
6. Gaillot, O., M. Wetsch, N. Fortineau, and P. Berche. 2000. Evaluation of
CHROMagar Staph. aureus, a new chromogenic medium, for isolation and
presumptive identification of Staphylococcus aureus from human clinical
specimens. J. Clin. Microbiol. 38:15871591.
7. Kluytmans, J., H. Berg, P. Steegh, F. Vandenesch, J. Etienne, and A. Van
Belkum. 1998. Outbreak of Staphylococcus schleiferi wound infections: strain
characterization by randomly amplified polymorphic DNA analysis, PCR
ribotyping, conventional ribotyping, and pulsed-field gel electrophoresis.
J. Clin. Microbiol. 36:22142219.
8. Langlet, S., G. Quentin, G. Contant, and J. C. Ghnassia. 1999. Methode
chromogenique didentification rapide de Staphylococcus aureus. Ann. Biol.
Clin. 57:191196.
9. Mahoudeau, I., X. Delabranche, G. Prevost, H. Monteil, and Y. Piemont.
1997. Frequency of isolation of Staphylococcus intermedius from humans.
J. Clin. Microbiol. 35:21532154.
10. Monnery, I., A. M. Freydiere, C. Baron, A. M. Rousset, S. Tigaud, M.
Boude-Chevalier, H. de Montclos, and Y. Gille. 1994. Evaluation of two new
chromogenic media for detection of Salmonella in stools. Eur. J. Clin. Microbiol. Infect. Dis. 13:257261.
11. Odds, F. C., and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important
Candida spp. J. Clin. Microbiol. 32:19231929.
12. Peacock, S. J., G. Lina, J. Etienne, and T. J. Foster. 1999. Staphylococcus
schleiferi subsp. schleiferi expresses a fibronectin-binding protein. Infect. Immun. 67:42724275.
13. Personne, P., M. Be`s, G. Lina, F. Vandenesch, I. Brun, and J. Etienne. 1997.
Comparative performances of six agglutination kits assessed by using typical
and atypical strains of Staphylococcus aureus. J. Clin. Microbiol. 35:1138
1140.
14. Raus, J., and D. N. Love. 1990. Comparison of the staphylocoagulase activities of Staphylococcus aureus and Staphylococcus intermedius on Chromozym-TH. J. Clin. Microbiol. 28:207210.